Drug intelligence / Profile preview

tulathromycin + ketoprofen

Development stage
Unknown
Lead developer
Zoetis
Modality
Small Molecules
Administration
Subcutaneous
01

Overview

Tulathromycin + ketoprofen is a veterinary combination injectable solution pairing tulathromycin, a long-acting triamilide macrolide antibiotic, with ketoprofen, a racemic nonsteroidal anti-inflammatory drug (NSAID), for the treatment of bovine respiratory disease (BRD) and concurrent control of fever in cattle. Tulathromycin exerts bacteriostatic activity by selectively binding to the bacterial 50S ribosomal subunit and inhibiting essential protein synthesis, leading to disruption of respiratory pathogens such as Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis, while ketoprofen provides rapid antipyretic and anti-inflammatory effects via cyclooxygenase inhibition and reduced prostaglandin and thromboxane A2 synthesis.[1][3][7] A single subcutaneous dose delivering 2.5 mg/kg tulathromycin and 3 mg/kg ketoprofen maintains therapeutic tulathromycin exposure for approximately two weeks and improves early pyrexia and clinical signs compared with tulathromycin alone, offering a convenient one-shot therapy aimed at both infection control and improved animal welfare in feedlot and beef cattle.[1][3][7]

02

Targets

Bacterial 50S ribosomal subunitTBXAS1 (Thromboxane A2 synthase)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on tulathromycin + ketoprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tulathromycin + ketoprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call